Diabetes Subtypes and Kid Obesity; Wegovy Redefining ‘Thin’? FDA’s ‘Healthy’ Food

Children with obesity likely face a higher risk for four subtypes of adult-onset diabetes: latent autoimmune diabetes, severe insulin-deficient diabetes, severe insulin-resistant diabetes, and mild obesity-related diabetes. (Diabetologia)

A meta-analysis of 10 studies found that the use of SGLT2 inhibitors and GLP-1 receptor agonists were linked with a significantly lower risk for all-cause dementia. (Journal of the American Geriatrics Society)

Is the growing off-label use of semaglutide (Ozempic, Wegovy) changing the definition of what it means to be “thin”? (The Cut)

Meanwhile, too many people who don’t have diabetes or obesity are getting access to semaglutide and tirzepatide (Mounjaro), creating problems for patients who truly need them. (ABC News)

Maternal obesity may adversely change the placenta structure more than gestational diabetes, as seen in a study of South African women. (Journal of Physiology)

A Michigan-based endocrinologist was sentenced to 8 months in prison for tax evasion related to his medical practice, the Department of Justice announced.

Is the FDA’s proposed definition of a “healthy” food too strict? You bet your sweet pickle it is, some food manufacturers say. (STAT)

Smartphone-delivered cognitive behavioral therapy helped people with type 2 diabetes significantly slash their glucose levels versus standard care in a 6-month trial, according to a study to be presented at the American College of Cardiology’s annual scientific session.

Annual serological screenings for autoimmune thyroid disease may be helpful for female patients with a family history and anti-nuclear antibody (ANA)-positive juvenile idiopathic arthritis. (Pediatric Rheumatology)

About two-thirds of pituitary microadenomas either didn’t change in size or shrunk over a median follow-up of 5 years. (Annals of Internal Medicine)